[Skip to content]

EPDA - European Parkinsons Disease Association EPDA - European Parkinsons Disease Association EPDA - European Parkinsons Disease Association EPDA - European Parkinsons Disease Association EPDA - European Parkinsons Disease Association EPDA - European Parkinsons Disease Association EPDA - European Parkinsons Disease Association EPDA - European Parkinsons Disease Association
EPDA - European Parkinsons Disease Association
LIFE WITH PARKINSON'S
.

VIRI

  • Italija: Totaro R, Marini C, Pistoia F, Sacco S, Russo T, Carolei A. Prevalence of Parkinson’s disease in the L’Aquila district, central Italy. Acta Neurol Scand. 2005; 112(1):24-28.
  • Španija: Errea JM, Ara JR, Aibar C, de Pedro-Cuesta J. Prevalence of Parkinson’s disease in lower Aragon, Spain. Mov Disord. 1999 Jul;14(4):596-604.
  • Francija: Tison F, Dartigues JF, Dubes L, Zuber M, Alperovitch A, Henry P. Prevalence of Parkinson’s disease in the elderly: a population study in Gironde, France. Acta Neurol Scand. 1994 Aug;90(2):111-5.
  • Portugalska: Dias JA, Felgueiras MM, Sanchez JP, Gonçalves JM, Falcäo JM, Pimenta ZP. The prevalence of Parkinson’s disease in Portugal. A population approach. Eur J Epidemiol. 1994 Dec;10(6):763-7.
  • VB: Schrag A, Ben-Shlomo Y, Quinn NP.Cross sectional prevalence survey of idiopathic Parkinson’s disease and Parkinsonism in London. BMJ. 2000 Jul 1;321(7252):21-2.
  • Finska: Havulinna AS, Tienari PJ, Marttila RJ, Martikainen KK, Eriksson JG, Taskinen O et al. Geographical variation of medicated parkinsonism in Finland during 1995 to 2000. Mov Disord. 2008; 23(7):1024-1031.
  • Nizozemska: van de Vijver DA, Stricker BH, Breteler MM, Roos RA, Porsius AJ, de Boer A. Evaluation of antiparkinsonian drugs in pharmacy records as a marker for Parkinson’s disease. Pharm World Sci. 2001; 23(4):148-52.
  • Litva: Valeikiene V, Ceremnych J, Mieliauskaite D, Alekna V. The prevalence of Parkinson’s disease among Vilnius inhabitants. Central European Journal of Medicine 2008; 3(2):195-198.